PURDUE PHARMA, LP for PURDUE PHARMA LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Line Extension as relates to Abuse Deterrent Formulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Copyright/Patent/Trademark CPT
Line Extension as relates to Abuse Deterrent Formulations Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Line Extension as relates to Abuse Deterrent Formulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.